Effect of S-methylisothiourea, an inducible nitric oxide synthase inhibitor, in joint pain and pathology in surgically induced model of osteoarthritis

References

• Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007;213:626–34
   PubMed Web of Science ®Google Scholar
• Fernandes JC, Martel-Pelletier J, Pelletier, JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002;39:237–46
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237–47
   PubMed Web of Science ®Google Scholar
• Guilak F, Fermor B, Keefe FJ, Kraus VB, Olson SA, Pisetsky DS, Setton LA, Weinberg JB. The role of biomechanics and inflammation in cartilage injury and repair. Clin Orthopaed Res 2004;423:17–26
   PubMed Web of Science ®Google Scholar
• Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthrit Res Ther 2008;10:S2 (doi:10.1186/ar2463).
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, Martel-Pelletier J. Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor. Osteoarthr Cartilage 1999;7:416–18
   PubMed Web of Science ®Google Scholar
• Studer RK, Levicoff E, Georgescu H, Miller L, Jaffurs D, Evans C. Nitric oxide inhibits chondrocyte response to IGF1: inhibition of IGF-1Rbeta tyrosine phosphorylation. Am J Physiol 2000;279:961–69
   PubMedGoogle Scholar
• Studer R, Jaffurs D, Stefanovic-Racic M, Robbins PD, Evans CH. Nitric oxide in osteoarthritis. Osteoarthr Cartilage 1999;7:377–79
   PubMed Web of Science ®Google Scholar
• Hancock CM, Riegger-Krugh C. Modulation of pain in osteoarthritis: the role of nitric oxide. Clin J Pain 2008;24:353–65
   PubMed Web of Science ®Google Scholar
• McInnes IB, Leung Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996;184:1519–24
   PubMed Web of Science ®Google Scholar
• Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske. J., Stuchin SA, Patel IR, Abramson SB. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 1997;99:1231–37
   PubMed Web of Science ®Google Scholar
• Grabowski PS, Wright PK, Vanthof RJ, Helfrich MH, Ohshima H, Ralston SH. Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1997;36:651–55
   PubMedGoogle Scholar
• Abramson SB, Attur M, Amin AR, Clancy R. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 2001;3:535–41
   PubMedGoogle Scholar
• Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, Di Battista JA, Martel-Pelletier J. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275–86
   PubMed Web of Science ®Google Scholar
• Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994;37:1062–69
   PubMed Web of Science ®Google Scholar
• Ialenti A, Moncada S, DiRosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 1993;110:701–6
   PubMed Web of Science ®Google Scholar
• Connor JR, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK, Tjoeng FS, Currie MG. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 1995;273:15–24
   PubMed Web of Science ®Google Scholar
• More AS, Kumari RR, Gupta G, Lingaraju MC, Balaganur V, Pathak NN, Kumar D, Kumar D, Sharma AK, Tandan SK. Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoarthritic pain: implication for osteoarthritis therapy. Pharmacol Biochem Behav 2013;103:764–72
   PubMed Web of Science ®Google Scholar
• Castro RR, Cunha FQ, Silva JrFS, Rocha FA. A quantitative approach to measure joint pain in experimental osteoarthritis—evidence of a role for nitric oxide. Osteoarthr Cartilage 2006;14:769–76
   PubMed Web of Science ®Google Scholar
• Wu Q, Henry JL. Changes in Aβ non-nociceptive primary sensory neurons in a rat model of osteoarthritis pain. Mol Pain 2010;6:37
   PubMedGoogle Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JK, Tannenbaum SR. Analysis of nitrate, nitrite and 15N in biological fluids. Anal Biochem 1982;126:131–36
   PubMed Web of Science ®Google Scholar
• Farndale RW, Buttle GJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883:173–77
   PubMed Web of Science ®Google Scholar
• Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996;29:225–29
   PubMed Web of Science ®Google Scholar
• Vachon AM, Keeley FW, Mc Ilwraith CW. Biochemical analysis of normal articular cartilage in horses. Am J Vet Res 1990;51:1905–11
   PubMed Web of Science ®Google Scholar
• Hayami T, Pickarski M, Zhuo Y, Wesolowski GA, Rodan GA, Duong LT. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 2006;38:234–43
   PubMed Web of Science ®Google Scholar
• Rocha, FAC, Silva, Jr. FS, Leite, ACRM, Leite, AKRM, Girão, VCC, Castro RR, Cunha FQ. Tadalafil analgesia in experimental arthritis involves suppression of intra-articular TNF release. Br J Pharmacol 2011;164:828–35
   PubMed Web of Science ®Google Scholar
• Beyreuther B, Callizot N, Stöhr T. Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain. Arthr Res Ther 2007;9:14
   PubMed Web of Science ®Google Scholar
• So HS, Jung BH, Song HS, Myung K, Park JS, Chae KM. Nitric oxide prevents the IFN-gamma/LPS-induced hepatotoxicity in a protein kinase G-independent manner. Immunopharmacol Immunotoxicol 2001;23:321–34
   PubMed Web of Science ®Google Scholar
• Ferland CE, Laverty S, Beaudry F, Vachon P. Gait analysis and pain response of two rodent models of osteoarthritis. Pharmacol Biochem Behav 2011;97:603–10
   PubMed Web of Science ®Google Scholar
• Chen JJ, Hung KC, Lu K, Yu SW, Chang CC, Liu CC, Spielberger J, Ku PY, Tan PH. The pre-emptive analgesic effect of a cyclooxygenase-2 inhibitor in a rat model of acute postoperative pain. Anaesthesia 2012;67:1225–31
   PubMed Web of Science ®Google Scholar
• Harvey VL, Dickenson AH. Behavioural and electrophysiological characterisation of experimentally induced osteoarthritis and neuropathy in C57Bl/6 mice. Mol Pain 2009;5:18
   PubMedGoogle Scholar
• Vermeirsch H, Biermans R, Salmon PL, Meert TF. Evaluation of pain behavior and bone destruction in two arthritic models in guinea pig and rat. Pharmacol Biochem Behav 2007;87:349–59
   PubMed Web of Science ®Google Scholar
• Liu P, Okun A, Ren J, Guo RC, Ossipov MH, Xie J. Ongoing pain in the MIA model of osteoarthritis. Neurosci Lett 2011;493:72–5
   PubMed Web of Science ®Google Scholar
• Im HJ, Kim JS, Li X, Kotwal N, Sumner DR, Van Wijnen AJ. Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum 2010;62:2995–3005
   PubMed Web of Science ®Google Scholar
• Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, Kidd B, Bevan S, Winter J. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 2004;112:83–93
   PubMed Web of Science ®Google Scholar
• Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, Walker K. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005;114:339–46
   PubMed Web of Science ®Google Scholar
• Ivanavicius SP, Ball AD, Heapy CG, Westwood FR, Murray F, Read SJ. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation. Pain 2007;128:272–82
   PubMed Web of Science ®Google Scholar
• LeBars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001;53:597–652
   PubMed Web of Science ®Google Scholar
• Scadding JW, Koltzenburg M. Painful peripheral neuropathies. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack's textbook of pain. 5th ed. China: Elsevier; 2006:973–99
   Google Scholar
• Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, Walker K. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005;114:339–46
   PubMed Web of Science ®Google Scholar
• Vonsy JL, Ghandehari J, Dickenson AH. Differential analgesic effects of morphine and gabapentin on behavioural measures of pain and disability in a model of osteoarthritis pain in rats. Eur J Pain 2008;13:786–93
   PubMed Web of Science ®Google Scholar
• Nishida K, Doi T, Matsuo M, Ishiwari Y, Tsujigiwa H, Yoshida A, Shibahara M, Inoue H. Involvement of nitric oxide in chondrocyte cell death in chondro-osteophyte formation. Osteoarthr Cartilage 2001;9:232–37
   PubMed Web of Science ®Google Scholar
• Hauselmann HJ, Stefanovic-Racic M, Michel BA, Evans CH. Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases. J Immunol 1998;160:1444–48
   PubMed Web of Science ®Google Scholar
• Wahl SM, Cartney-Francis N, Chan J, Dionne R, Ta L, Orenstein JM. Nitric oxide in experimental joint inflammation. Benefit or detriment. Cells Tissues Organs 1998;174:26–33
   Google Scholar
• Martel-Pelletier J, Lajeunesse D, Pelletier JP. Arthritis and allied conditions. In: Koopman WJ, Moreland LW, eds. A textbook of rheumatology. 15th ed. Baltimore, MA: Lippincott Williams & Wilkins; 2005:2199–26
   Google Scholar
• Thomas DP, King B, Stephens T, Dingle JT. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1. Ann Rheum Dis 1991;50:75–80
   PubMed Web of Science ®Google Scholar
• Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor α in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306–10
   PubMed Web of Science ®Google Scholar
• Aktas E, Sener E, Zengin O, Gocun PU, Deveci MA. Serum TNF-alpha levels: potential use to indicate osteoarthritis progression in a mechanically induced model. Eur J Orthop Surg Traumatol 2012;22:119–22
   Web of Science ®Google Scholar
• Boileau C, Martel-Pelletier J., Moldovan F. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide. Arthritis Rheum 2002;46:2637–47
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Jovanovic DV, Lascau-Coman V. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum 2000;43:1290–9
   PubMed Web of Science ®Google Scholar
• Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P. Mono-iodoacetate-induced experimental osteoarthritis. A dose–response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 1997;40:1670–79
   PubMed Web of Science ®Google Scholar
• Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol 2003;31:619–24
   PubMed Web of Science ®Google Scholar
• Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J Med 2006;354:841–48
   PubMed Web of Science ®Google Scholar